GSK plc (GSK1N)
BMV
Closed
Aug 21, 2026
Day's Range
426.2752 wk Range
356.95Profile - GSK1N - GSK plc
Profile
Mic Code
XMEX
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
68.62K
GSK plc is a British multinational pharmaceutical and biotechnology company headquartered in London, England. The company focuses on discovering, developing, and manufacturing prescription medicines and vaccines for a wide range of diseases. GSK plc operates as a focused biopharma business, with research and development centred on four core therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases. Its portfolio includes specialty medicines for complex conditions, vaccines used in national immunisation programmes, and general medicines addressing common chronic and acute illnesses. GSK plc serves healthcare systems, hospitals, and pharmacies worldwide, working closely with governments and global health organisations. As one of the larger global players in pharmaceuticals and vaccines, it plays a significant role in areas such as respiratory health, antiviral treatments, and prevention of infectious diseases through vaccination. Founded in 1999 and publicly listed in the United Kingdom, GSK plc today is a key constituent of the global healthcare and life sciences sector.
Profile Details
Type
Common Stock
Ceo
Ms. Emma Natasha Walmsley
Address
79 New Oxford Street
City
London
Zip
WC1A 1DG
Country
United Kingdom
Phone
44 20 8047 5000
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
